About cardiac markers
Cardiac markers are used for risk stratification and diagnosis of patients with suspected acute coronary syndrome and chest pain. Cardiac marker imaging is an effective, less expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure. The cardiac marker testing is widely used in many medical settings especially for patients at low risk for cardiac death and patients with arteriosclerosis, conjunctive heart failure, sudden cardiac arrest, and myocardial infraction. The various types of cardiac markers are:
• Troponin test
• Creatine Kinase test
• Lactate dehydrogenase
• Aspartate transaminase
• Myoglobin
• Ischemia-modified albumin
• Pro-brain natriuretic peptide
• Glycogen phosphorylase isoenzyme BB
The other cardiac markers are C-reactive protein, homocysteine, pulmonary embolism (D-dimer test), and high-density and low-density lipoproteins.
Technavio's analysts forecast the global cardiac markers market to grow at a CAGR of 9.64% during 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global cardiac markers market for 2015-2019. The market can be divided into the following segments:
• By diagnosis facility: POC testing and laboratory testing
• By assay type: Troponin I and BNP
Technavio's report, Global Cardiac Markers Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Abbott
• Alere
• Roche Diagnostics
• Siemens Healthcare
Other prominent vendors
• AniBiotech
• Axis-Shield
• Beckman Coulter
• Becton, Dickinson and Company
• BG Medicine
• Biomerieux
• Boston Scientific
• Critical Diagnostics
• diaDexus
• LifeSign
• Mitsubishi Chemical Europe
• Nanomix
• Radiometer Medical
• Randox Laboratories
• Response Biomedical
• Sierra Resources International
• Singulex
• Thermo Fisher Scientific
• Trinity Biotech
Key market driver
• Early diagnosis and preventive medicine
• For a full, detailed list, view our report
Key market challenge
• Lack of specific actions for detection of cardiac disorders
• For a full, detailed list, view our report
Key market trend
• Increased usage of POC diagnostic tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Cardiac markers overview
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Market segmentation by assay type
Global troponin I market
Global BNP market
PART 08: Market segmentation by diagnostic facility
Global cardiac POC testing market
Global cardiac laboratory testing market
PART 09: Geographical segmentation
Geographical segmentation of global cardiac markers market
Cardiac markers market in Americas
Cardiac markers market in EMEA
Cardiac markers market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 16: Key vendor analysis
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Healthcare
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List Of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Cardiac marker tests and their respective cost savings
Exhibit 03: Characteristics of cardiac markers
Exhibit 04: Segmentation of global cardiac markers market by disease applications 2014
Exhibit 05: Global cardiac markers market segmentation
Exhibit 06: Global cardiac markers market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global cardiac markers market by assay type
Exhibit 09: Segmentation of global cardiac markers market by assay type 2014
Exhibit 10: Segmentation of global cardiac markers market by assay type 2019
Exhibit 11: Segmentation of global cardiac markers market by assay type 2014-2019
Exhibit 12: Global troponin I market 2014-2019 ($ billions)
Exhibit 13: Global BNP market 2014-2019 ($ millions)
Exhibit 14: Segmentation of global cardiac markers market by diagnostic facility
Exhibit 15: Segmentation of global cardiac markers market by diagnosis facility 2014
Exhibit 16: Segmentation of global cardiac markers market by diagnostic facility 2019
Exhibit 17: Segmentation of global cardiac markers market by diagnostic facility 2014-2019
Exhibit 18: Global cardiac POC testing market 2014-2019 ($ millions)
Exhibit 19: Segmentation of global cardiac POC testing market by assay type
Exhibit 20: Global troponin I market in POC setting 2014-2019 ($ millions)
Exhibit 21: Global BNP market in POC setting 2014-2019 ($ millions)
Exhibit 22: Segmentation of global cardiac POC testing market by geography 2014
Exhibit 23: Global cardiac laboratory testing market 2014-2019 ($ billions)
Exhibit 24: Segmentation of global cardiac laboratory testing market by assay type
Exhibit 25: Global troponin I market in laboratory setting 2014-2019 ($ millions)
Exhibit 26: Global BNP market in laboratory setting 2014-2019 ($ millions)
Exhibit 27: Segmentation of global cardiac laboratory testing market by geography 2014
Exhibit 28: Segmentation of global cardiac markers market by geography 2014
Exhibit 29: Segmentation of global cardiac markers market by geography 2019
Exhibit 30: Segmentation of global cardiac markers market by geography 2014-2019
Exhibit 31: Cardiac markers market in Americas 2014-2019 ($ billions)
Exhibit 32: Cardiac markers market in EMEA 2014-2019 ($ millions)
Exhibit 33: Cardiac markers market in APAC 2014-2019 ($ millions)
Exhibit 34: Impact of drivers
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Abbott: Key takeaways
Exhibit 37: Alere: Key takeaways
Exhibit 38: Roche Diagnostics: Key takeaways
Exhibit 39: Siemens Healthcare: Key takeaways
Exhibit 40: Abbott Diagnostics: Key business offerings
Exhibit 41: Alere: Business segmentation by revenue 2014
Exhibit 42: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 43: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
